In 2014, a diagnostic iteration of the latter model, named GALAD [13], replaced bilirubin and albumin with the patient’s age and sex to predict the presence of HCC; the model score appears to be proportional to the tumor cell mass and performs substantially better than any individual biomarker. Here, ALB is linked to neoplasm.